The REMEDIUM research project aims to critically investigate and offer innovative solutions and recommendations to improve the EU health system's sustainability by rethinking legal and regulatory pharma incentives, health crisis preparedness, and unmet medical needs to preserve a society's health resilience as a remedy for existing threats and emergencies.

The project focuses on an interdisciplinary approach and addresses the intersection of patent law, pharmaceutical regulations, and public health. It explores whether the current EU regulatory and intellectual property systems, mainly based on patent exclusivity, provide legal and regulatory tools and incentives to ensure competitiveness, innovation and sustainability of the EU’s pharmaceutical industry and remain fit for purpose in promoting equitable access to medicines, or whether alternative regulatory incentives and interpretive strategies should be implemented. It also addresses a demand for new reforms aimed at crisis preparedness and response mechanisms in the EU through a legal and regulatory framework. Finally, by taking a societal approach, its goal is to deliver legal solutions that respond to urgent civilisational and technological developments, particularly those at the crossroads of intellectual property, innovation, and public health 

• Dr hab. Justyna Ożegalska-Trybalska,
  prof. UJ – liderka

• Dr Laura Valtere,
  LL.M. - CeBIL, University of Copenhagen
  współpracowniczka zagraniczna

• Prof. Christoph Redemacher, 
  Waseda University RCLIP

• Dr Gabriela Lenarczyk,
  LL.M. CeBIL, University of Copenhagen

• Dr Dariusz Kasprzycki,
  UJ